Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16335584rdf:typepubmed:Citationlld:pubmed
pubmed-article:16335584lifeskim:mentionsumls-concept:C0085278lld:lifeskim
pubmed-article:16335584lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:16335584pubmed:issue11lld:pubmed
pubmed-article:16335584pubmed:dateCreated2005-12-12lld:pubmed
pubmed-article:16335584pubmed:abstractTextCatastrophic antiphospholipid syndrome (CAPS) is a rare complication of antiphospholipid syndrome. It is a disseminated severe vascular pathology which presents with multi-organic dysfunction that progresses rapidly. Prognosis ends up being fatal in half of the cases. It may appear during pregnancy, surgery, infection, or after suspension of anticoagulation therapy. We studied two female patients with CAPS who survived after treatment with anticoagulation therapy and intravenous corticosteroids. The evolution of our two patients, after 17 months of follow-up under oral anticoagulant treatment was favourable and they are currently asymptomatic. In these patients the early diagnosis and treatment were essential to enhance their possibilities of survival.lld:pubmed
pubmed-article:16335584pubmed:languageenglld:pubmed
pubmed-article:16335584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16335584pubmed:citationSubsetIMlld:pubmed
pubmed-article:16335584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16335584pubmed:statusMEDLINElld:pubmed
pubmed-article:16335584pubmed:issn0961-2033lld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:HidalgoCClld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:Jiménez-Alons...lld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:MacíasPPlld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:NavarreteNNlld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:CálizRRlld:pubmed
pubmed-article:16335584pubmed:authorpubmed-author:JaénFFlld:pubmed
pubmed-article:16335584pubmed:issnTypePrintlld:pubmed
pubmed-article:16335584pubmed:volume14lld:pubmed
pubmed-article:16335584pubmed:ownerNLMlld:pubmed
pubmed-article:16335584pubmed:authorsCompleteYlld:pubmed
pubmed-article:16335584pubmed:pagination907-9lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:meshHeadingpubmed-meshheading:16335584...lld:pubmed
pubmed-article:16335584pubmed:year2005lld:pubmed
pubmed-article:16335584pubmed:articleTitleTwo cases of catastrophic antiphospholipid syndrome.lld:pubmed
pubmed-article:16335584pubmed:affiliationService of Internal Medicine, Virgen de las Nieves University Hospital, Granada, Spain. nurianavarrete@latinmail.comlld:pubmed
pubmed-article:16335584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16335584pubmed:publicationTypeCase Reportslld:pubmed